These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24166986)

  • 1. Uncertain diagnosis after newborn screening for cystic fibrosis: An ethics-based approach to a clinical dilemma.
    Massie J; Gillam L
    Pediatr Pulmonol; 2014 Jan; 49(1):1-7. PubMed ID: 24166986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J; Clements B;
    Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.
    Padman R; Flathers K; Passi V
    Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Newborn screening for cystic fibrosis, a clinical geneticist perspective].
    Sanak M
    Przegl Lek; 2011; 68(1):14-6. PubMed ID: 21563437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test.
    Lang CW; McColley SA; Lester LA; Ross LF
    Pediatrics; 2011 Feb; 127(2):276-83. PubMed ID: 21220393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 10. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for cystic fibrosis.
    Gonska T; Ratjen F
    Expert Rev Respir Med; 2015 Oct; 9(5):619-31. PubMed ID: 26366807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
    Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
    Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for cystic fibrosis.
    Wagener JS; Zemanick ET; Sontag MK
    Curr Opin Pediatr; 2012 Jun; 24(3):329-35. PubMed ID: 22491493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.
    Beucher J; Leray E; Deneuville E; Roblin M; Pin I; Bremont F; Turck D; Giniès JL; Foucaud P; Rault G; Derelle J; David V; Journel H; Marchand S; Veillard D; Roussey M
    J Pediatr; 2010 May; 156(5):771-6, 776.e1. PubMed ID: 20171652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program.
    Doull IJ; Hall SJ; Bradley DM
    Pediatr Pulmonol; 2007 Sep; 42(9):773-8. PubMed ID: 17659601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cystic fibrosis. Ethical and social issues.
    Kerem E; Lynch A
    Am Rev Respir Dis; 1991 Mar; 143(3):457-60. PubMed ID: 2001051
    [No Abstract]   [Full Text] [Related]  

  • 18. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
    N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.